LA
ABBV icon

Lifeworks Advisors’s AbbVie ABBV Stock Holding History

Lifeworks Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.63M Buy
39,697
+2,436
+7% +$540K 1.11% 19
2025
Q4 		$8.51M Sell
37,261
-6,837
-16% -$1.56M 1.1% 15
2025
Q3 		$10.2M Sell
44,098
-2,326
-5% -$474K 1.36% 11
2025
Q2 		$8.62M Buy
46,424
+1,575
+4% +$293K 1.28% 16
2025
Q1 		$9.4M Buy
44,849
+2,814
+7% +$547K 1.56% 10
2024
Q4 		$7.47M Buy
42,035
+8,337
+25% +$1.53M 1.35% 12
2024
Q3 		$6.65M Buy
33,698
+1,269
+4% +$237K 1.31% 15
2024
Q2 		$5.56M Buy
32,429
+4,448
+16% +$737K 1.55% 19
2024
Q1 		$5.1M Buy
27,981
+2,268
+9% +$391K 1.43% 17
2023
Q4 		$3.98M Buy
25,713
+482
+2% +$70.3K 1.37% 19
2023
Q3 		$3.76M Buy
25,231
+940
+4% +$138K 1.46% 19
2023
Q2 		$3.27M Buy
24,291
+3,911
+19% +$574K 1.39% 20
2023
Q1 		$3.25M Sell
20,380
-325
-2% -$49.7K 1.53% 18
2022
Q4 		$3.35M Buy
20,705
+97
+0.5% +$14.9K 1.88% 15
2022
Q3 		$3.02M Sell
20,608
-3,531
-15% -$507K 1.72% 18
2022
Q2 		$3.7M Buy
24,139
+2,504
+12% +$383K 2.34% 7
2022
Q1 		$3.51M Buy
21,635
+6,390
+42% +$928K 2.32% 7
2021
Q4 		$2.06M Buy
+15,245
New +$1.8M 1.64% 13

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lifeworks Advisors's ABBV Position: Q1 2026 in Review

Lifeworks Advisors increased its AbbVie (ABBV) stake by 6.5% in Q1 2026, buying an estimated $540K and bringing the position to 39,697 shares worth $8.63M. The position accounts for 1.11% of the portfolio, ranked #19.

Lifeworks Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $10.2M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Lifeworks Advisors held 39,697 shares of AbbVie worth $8.63M as of Q1 2026.
  • Lifeworks Advisors bought 2,436 AbbVie shares in Q1 2026, an estimated $540K.
  • AbbVie made up 1.11% of Lifeworks Advisors's portfolio in Q1 2026, its #19 holding.
  • Lifeworks Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Lifeworks Advisors's AbbVie position peaked at $10.2M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.